Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMS Site
mi
from
Winston Salem, NC
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMS Site
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Toledo, OH
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Toledo, OH
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Desoto, TX
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Desoto, TX
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Calgary,
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Calgary,
Click here to add this to my saved trials
Obesity, Inflammation and Oxidative Stress
Obesity, Inflammation and Oxidative Stress
Status: Enrolling
Updated:  11/30/2015
Kaiser Permanente of Northern California, Division of Research
mi
from
Oakland, CA
Obesity, Inflammation and Oxidative Stress
Obesity, Inflammation and Oxidative Stress
Status: Enrolling
Updated: 11/30/2015
Kaiser Permanente of Northern California, Division of Research
mi
from
Oakland, CA
Click here to add this to my saved trials
The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population
The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population
Status: Enrolling
Updated:  11/30/2015
Children's Hospital Colorado
mi
from
Aurora, CO
The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population
The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population
Status: Enrolling
Updated: 11/30/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome
Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome
Status: Enrolling
Updated:  12/1/2015
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome
Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome
Status: Enrolling
Updated: 12/1/2015
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Click here to add this to my saved trials
Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
Status: Enrolling
Updated:  12/3/2015
University of Texas Medical Branch
mi
from
Galveston, TX
Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
Status: Enrolling
Updated: 12/3/2015
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated:  12/4/2015
Information on additional locations involved in this clinical trial contact Chelsea Therapeutics
mi
from
Charlotte, NC
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
Information on additional locations involved in this clinical trial contact Chelsea Therapeutics
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated:  12/4/2015
Wisconsin Institute for Neurology and Sleep Disorders
mi
from
Milwaukee, WI
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
Wisconsin Institute for Neurology and Sleep Disorders
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated:  12/4/2015
NYU Langone Medical Center
mi
from
New York, NY
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated:  12/8/2015
Childrens National Medical Center
mi
from
Washington,
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated: 12/8/2015
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated:  12/8/2015
Lucile Packard Children's Hospital at Stanford
mi
from
Palo Alto, CA
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated: 12/8/2015
Lucile Packard Children's Hospital at Stanford
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated:  12/8/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated: 12/8/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated:  12/8/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated: 12/8/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated:  12/8/2015
University Hospitals of Cleveland/Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated: 12/8/2015
University Hospitals of Cleveland/Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated:  12/8/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated: 12/8/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated:  12/8/2015
Children's Hospital Boston
mi
from
Boston, MA
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Status: Enrolling
Updated: 12/8/2015
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Glass Ionomer Sealant and Fluoride Varnish Study to Prevent Early Childhood Caries
Glass Ionomer Sealant and Fluoride Varnish Randomized Clinical Trial
Status: Enrolling
Updated:  12/9/2015
San Ysidro Health Center
mi
from
San Ysidro, CA
Glass Ionomer Sealant and Fluoride Varnish Study to Prevent Early Childhood Caries
Glass Ionomer Sealant and Fluoride Varnish Randomized Clinical Trial
Status: Enrolling
Updated: 12/9/2015
San Ysidro Health Center
mi
from
San Ysidro, CA
Click here to add this to my saved trials
Transcranial Stimulation (tDCS) For the Treatment of Neuropathic Facial Pain
Transcranial Stimulation (TDCS) For The Treatment of Neuropathic Facial Pain.
Status: Enrolling
Updated:  12/9/2015
Beth Israel Med Ctr
mi
from
New York, NY
Transcranial Stimulation (tDCS) For the Treatment of Neuropathic Facial Pain
Transcranial Stimulation (TDCS) For The Treatment of Neuropathic Facial Pain.
Status: Enrolling
Updated: 12/9/2015
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Impact of Nutritional Supplementation on Aerobic Performance and Fatigue
Impact of Nutritional Supplementation on Aerobic Performance and Fatigue
Status: Enrolling
Updated:  12/9/2015
Health and Exercise Science Laboratory
mi
from
Tampa, FL
Impact of Nutritional Supplementation on Aerobic Performance and Fatigue
Impact of Nutritional Supplementation on Aerobic Performance and Fatigue
Status: Enrolling
Updated: 12/9/2015
Health and Exercise Science Laboratory
mi
from
Tampa, FL
Click here to add this to my saved trials
Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy
Voluma Treatment of HIV Facial Lipoatrophy
Status: Enrolling
Updated:  12/9/2015
Sacramento VA Medical Center
mi
from
Mather, CA
Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy
Voluma Treatment of HIV Facial Lipoatrophy
Status: Enrolling
Updated: 12/9/2015
Sacramento VA Medical Center
mi
from
Mather, CA
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
Beth Israel Deaconess Medical Center (Harvard)
mi
from
Boston, MA
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
Beth Israel Deaconess Medical Center (Harvard)
mi
from
Boston, MA
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
New York University
mi
from
New York, NY
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
Vanderbilt University
mi
from
Nashville, TN
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
The Mayo Clinic
mi
from
Rochester, MN
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases
A Phase II Trial of Total Body Irradiation-Based Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients With Hematologic Malignancies
Status: Enrolling
Updated:  12/10/2015
Northside Hospital
mi
from
Atlanta, GA
Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases
A Phase II Trial of Total Body Irradiation-Based Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients With Hematologic Malignancies
Status: Enrolling
Updated: 12/10/2015
Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Inpatient Self Monitoring and Administration Study (ISMAS)
Inpatient Self Monitoring and Administration Study (ISMAS)
Status: Enrolling
Updated:  12/11/2015
Atlanta VA Medical Center
mi
from
Decatur, GA
Inpatient Self Monitoring and Administration Study (ISMAS)
Inpatient Self Monitoring and Administration Study (ISMAS)
Status: Enrolling
Updated: 12/11/2015
Atlanta VA Medical Center
mi
from
Decatur, GA
Click here to add this to my saved trials
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Status: Enrolling
Updated:  12/14/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Status: Enrolling
Updated: 12/14/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Penfield Pediatrics
mi
from
Penfield, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Penfield Pediatrics
mi
from
Penfield, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Westfall Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Westfall Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Lewis Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Lewis Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Sunrise Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Sunrise Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Long Pond Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Long Pond Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Legacy Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Legacy Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Pathway Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Pathway Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Alliance Urology Specialists
mi
from
Greensboro, NC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Alliance Urology Specialists
mi
from
Greensboro, NC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Citrus Valley Medical Research, Inc.
mi
from
Glendora, CA
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Citrus Valley Medical Research, Inc.
mi
from
Glendora, CA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Female Pelvic Medicine & Urogynecology Institute of MI
mi
from
Grand Rapids, MI
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Female Pelvic Medicine & Urogynecology Institute of MI
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Medical University of South Carolina
mi
from
Charleston, SC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
MetroHealth Med Ctr
mi
from
Cleveland, OH
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Premier Medical Group of the Hudson Valley PC
mi
from
Newburgh, NY
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Premier Medical Group of the Hudson Valley PC
mi
from
Newburgh, NY
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
The UrogynecologyCenter, LLC
mi
from
Overland Park, KA
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
The UrogynecologyCenter, LLC
mi
from
Overland Park, KA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Volunteer Research Group, University of Tennessee Medical Center
mi
from
Knoxville, TN
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Volunteer Research Group, University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
William Beaumont Hospitals
mi
from
Royal Oak, MI
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
William Beaumont Hospitals
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Atlantic Urological Associates
mi
from
Daytona Beach, FL
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Atlantic Urological Associates
mi
from
Daytona Beach, FL
Click here to add this to my saved trials